Added to YB: 2026-06-19
Pitch date: 2026-06-17
CAI [neutral]
Caris Life Sciences, Inc.
Author Info
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.
Market Cap
$5.1B
Pitch Price
N/A
Price Target
N/A
Dividend
N/A
EV/EBITDA
33.57
P/E
-10.01
EV/Sales
5.17
Sector
Biotechnology
Category
growth
Show full summary:
Caris Life Sciences: the Deepest Data in Oncology
CAI (overview): Oncology genomics co reading whole exome (~23K genes) vs Tempus' 648-panel. Rev $216M Q1'26 (+79%), positive EBITDA/FCF—only self-funding comp. Tissue ASP ~$4,300. Bull: re-mineable corpus, AI signatures, pricing power. Bear: pharma data rev only $75-85M '26 vs Tempus' $316M—breadth winning commercially. Depth vs breadth experiment.
Read full article (7 min)